πŸ‡ΊπŸ‡Έ FDA
Patent

US 10272039

Topical sodium nitrite formulation

granted A61KA61K33/00A61K45/06

Quick answer

US patent 10272039 (Topical sodium nitrite formulation) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K33/00, A61K45/06, A61K47/06, A61K9/0014